Training in medications for opioid use disorder and buprenorphine prescribing in the post X-waiver era: Insights from a nationwide, multispecialty survey
- 8 December 2025
- journal article
- Published by Elsevier in Preventive Medicine
- Vol. 203, 108485
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UM1TR004539)
- National Institutes of Health
- U.S. Department of Health and Human Services
- Health Resources and Services Administration (T32 HP10031)
This publication has 17 references indexed in Scilit:
- Asynchronous online training increased knowledge, confidence, and intent to screen and treat substance use disorders among primary care clinicians practicing in TexasPreventive Medicine, 2024
- Buprenorphine Dispensing after Elimination of the Waiver RequirementNew England Journal of Medicine, 2024
- Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studiesThe Lancet Psychiatry, 2023
- A Consensus-Based Checklist for Reporting of Survey Studies (CROSS)Journal of General Internal Medicine, 2021
- Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorderAddiction, 2018
- Medical Therapy for Heart Failure With Reduced Ejection FractionJACC, 2018
- Training in Office-Based Opioid Treatment with Buprenorphine in Us Residency Programs: A National Survey of Residency Program DirectorsSubstance Abuse, 2018
- Effect of Attending Practice Style on Generic Medication Prescribing by Residents in the Clinic Setting: An Observational StudyJournal of General Internal Medicine, 2015
- Chief Resident Case Experience and Autonomy Are Associated With Resident Confidence and Future Practice PlansJournal of Oral and Maxillofacial Surgery, 2013
- Comparing overdose mortality associated with methadone and buprenorphine treatmentDrug and Alcohol Dependence, 2009